Metabolic Diseases  >>  Apleway (tofogliflozin)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Apleway (tofogliflozin) / Kowa, Takeda
NCT00682097: A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus.

Completed
1
55
US, Europe
RO4998452, placebo
Hoffmann-La Roche
Diabetes Mellitus Type 2
03/09
03/09
NCT01044017: A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes

Completed
1
22
Europe
Placebo, RO4998452
Hoffmann-La Roche
Diabetes Mellitus Type 2
08/10
08/10
NCT00933972: A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment

Completed
1
36
US, RoW
RO4998452
Hoffmann-La Roche
Diabetes Mellitus Type 2
09/10
09/10

Download Options